Related Experiment Video
Updated: Mar 24, 2026
06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
3.2K
Towards new TB vaccines: What are the challenges?
Pathogens and Disease
|March 11, 2016
Summary
Developing new tuberculosis (TB) vaccines is crucial to combat drug-resistant strains. Despite challenges, continued support for TB vaccine research is vital for global public health.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly drug-resistant strains.
- The development of effective vaccines for TB, similar to HIV and malaria, is complex.
- TB presents a spectrum of disease, necessitating diverse vaccine strategies.
Purpose of the Study:
- To highlight the urgent need for novel and effective tuberculosis (TB) vaccines.
- To discuss the challenges in TB vaccine development, including identifying predictive biomarkers.
- To emphasize the importance of continued investment in TB vaccine research.
Main Methods:
- Review of current challenges in TB vaccine development.
- Analysis of the impact of previous vaccine trial outcomes (e.g., MVA-85A).
- Discussion on the need for biomarkers to predict vaccine efficacy.
Main Results:
- The development of effective TB vaccines is proving as challenging as for HIV and malaria.
- Lack of predictive biomarkers hinders the selection of promising vaccine candidates.
- The failure of MVA-85A may impact future TB vaccine research funding.
Conclusions:
- Effective TB vaccines are urgently required to control pulmonary TB and drug-resistant strains.
- Continued support and research are essential for advancing TB vaccine development.
- A successful TB vaccine would yield substantial public health benefits worldwide.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
628
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
628
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:28Pulmonary Tuberculosis V
761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
01:28Pulmonary Tuberculosis II
2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:23Vaccine Production
33
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
33